FCM
AMAG

Frontier Capital Management’s AMAG Pharmaceuticals AMAG Stock Holding History

Frontier Capital Management’s Portfolio AMAG Stock Details AMAG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-482,970
Closed -$26.4M – 379
2015
Q1 		$26.4M Buy
+482,970
New +$23M 0.19% 174

Other funds holding AMAG

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Frontier Capital Management's AMAG Position: Q2 2015 in Review

Frontier Capital Management sold out of AMAG Pharmaceuticals (AMAG) in Q2 2015, closing a stake of 482,970 shares — an estimated $26.4M sold.

Frontier Capital Management first reported a position in AMAG in Q1 2015 and held it in 1 quarter. The position peaked at $26.4M in Q1 2015. 208 funds tracked by Wall St. Rank hold AMAG as of Q2 2015.

  • Frontier Capital Management reported no remaining AMAG Pharmaceuticals position as of Q2 2015 after selling out during the quarter.
  • Frontier Capital Management sold 482,970 AMAG Pharmaceuticals shares in Q2 2015, an estimated $26.4M.
  • Frontier Capital Management first reported a position in AMAG Pharmaceuticals in Q1 2015 and held it in 1 quarter.
  • Frontier Capital Management's AMAG Pharmaceuticals position peaked at $26.4M in Q1 2015.
  • 208 funds tracked by Wall St. Rank held AMAG Pharmaceuticals as of Q2 2015.

Based on Frontier Capital Management's 13F filing for Q2 2015, filed 24 Jul 2015.